Immuneering (IMRX) Net Income (2020 - 2023)
Historic Net Income for Immuneering (IMRX) over the last 4 years, with Q4 2023 value amounting to -$15.5 million.
- Immuneering's Net Income fell 1543.57% to -$15.5 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$15.5 million, marking a year-over-year increase of 7051.25%. This contributed to the annual value of -$54.8 million for FY2023, which is 849.74% down from last year.
- Immuneering's Net Income amounted to -$15.5 million in Q4 2023, which was down 1543.57% from -$13.1 million recorded in Q3 2023.
- Over the past 5 years, Immuneering's Net Income peaked at -$3.6 million during Q2 2020, and registered a low of -$15.5 million during Q4 2023.
- In the last 4 years, Immuneering's Net Income had a median value of -$11.5 million in 2022 and averaged -$10.2 million.
- As far as peak fluctuations go, Immuneering's Net Income plummeted by 12162.34% in 2021, and later plummeted by 81.48% in 2023.
- Over the past 4 years, Immuneering's Net Income (Quarter) stood at -$5.8 million in 2020, then tumbled by 88.02% to -$11.0 million in 2021, then dropped by 22.75% to -$13.5 million in 2022, then fell by 15.44% to -$15.5 million in 2023.
- Its Net Income stands at -$15.5 million for Q4 2023, versus -$13.1 million for Q3 2023 and -$12.3 million for Q2 2023.